Literature DB >> 25070489

FTY720 reduces migration and invasion of human glioblastoma cell lines via inhibiting the PI3K/AKT/mTOR/p70S6K signaling pathway.

Li Zhang1, Handong Wang, Jianhong Zhu, Ke Ding, Jianguo Xu.   

Abstract

2-Amino-2-[2-(4-octylphenyl)]-1,3-propanediol hydrochloride (FTY720), a synthetic compound from Isaria sinclairii, has been proven to possess various biological benefits including anti-cancer activity. However, the effects and related mechanisms of FTY720 on the migration and invasion of glioblastoma cells are still unclear. In the present study, we utilized U251MG and U87MG human glioblastoma cell lines to assess the effects of FTY720. We found that FTY720 significantly inhibited migration and invasion of glioblastoma cells. The anti-migration and invasion effects of FTY720 were associated with its down-regulation of matrix metalloproteinase-2 (MMP-2) and MMP-9 while up-regulation of tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2. Furthermore, FTY720 modulated the expression of roundabouts 1 (ROBO1), Rho-associated kinase-1 (ROCK1), and epithelial-to-mesenchymal transition (EMT)-related factors. In addition, the phosphatidylinositide 3-kinases/protein kinase B/mammalian target of rapamycin/p70S6 kinase (PI3K/AKT/mTOR/p70S6K) signaling pathway participated in FTY720-mediated suppression of migration and invasion. Thus, our findings demonstrated that FTY720 reduced glioblastoma cells migration and invasion via multiple signaling pathways, suggesting that FTY720 is a potential therapeutic agent against glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25070489     DOI: 10.1007/s13277-014-2386-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.

Authors:  Gerald Schmid; Markus Guba; Ivan Ischenko; Armine Papyan; Mareile Joka; Sabine Schrepfer; Christiane J Bruns; Karl-Walter Jauch; Christopher Heeschen; Christian Graeb
Journal:  J Cell Biochem       Date:  2007-05-01       Impact factor: 4.429

Review 2.  FTY720 for cancer therapy (Review).

Authors:  Li Zhang; Han-Dong Wang; Xiang-Jun Ji; Zi-Xiang Cong; Jian-Hong Zhu; Yuan Zhou
Journal:  Oncol Rep       Date:  2013-10-01       Impact factor: 3.906

3.  FTY720 inhibits tumor growth and angiogenesis.

Authors:  G Schmid; M Guba; A Papyan; I Ischenko; M Brückel; C J Bruns; K-W Jauch; C Graeb
Journal:  Transplant Proc       Date:  2005 Jan-Feb       Impact factor: 1.066

4.  FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells.

Authors:  Craig T Wallington-Beddoe; John Hewson; Kenneth F Bradstock; Linda J Bendall
Journal:  Autophagy       Date:  2011-07-01       Impact factor: 16.016

Review 5.  Cadherins and epithelial-to-mesenchymal transition.

Authors:  Alexander Gheldof; Geert Berx
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

6.  β-Carotene inhibits neuroblastoma cell invasion and metastasis in vitro and in vivo by decreasing level of hypoxia-inducible factor-1α.

Authors:  Yoo-Sun Kim; Hyun-Ah Lee; Ji Ye Lim; Yang Kim; Chang-Hwan Jung; Sang-Ho Yoo; Yuri Kim
Journal:  J Nutr Biochem       Date:  2014-03-13       Impact factor: 6.048

7.  Knockdown of Nrf2 suppresses glioblastoma angiogenesis by inhibiting hypoxia-induced activation of HIF-1α.

Authors:  Xiangjun Ji; Handong Wang; Jianhong Zhu; Lin Zhu; Hao Pan; Wei Li; Yuan Zhou; Zixiang Cong; Feng Yan; Suihua Chen
Journal:  Int J Cancer       Date:  2014-01-10       Impact factor: 7.396

Review 8.  Epigenetic control of epithelial-mesenchymal-transition in human cancer.

Authors:  Tobias Kiesslich; Martin Pichler; Daniel Neureiter
Journal:  Mol Clin Oncol       Date:  2012-09-25

9.  The effect of ROCK-1 activity change on the adhesive and invasive ability of Y79 retinoblastoma cells.

Authors:  Jing Wang; Xiao-Hong Liu; Zi-Jian Yang; Bing Xie; Yi-Sheng Zhong
Journal:  BMC Cancer       Date:  2014-02-14       Impact factor: 4.430

10.  BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways.

Authors:  Wei Ren; Yuehong Liu; Shaoheng Wan; Chang Fei; Wei Wang; Yingying Chen; Zhihui Zhang; Ting Wang; Jinshu Wang; Lan Zhou; Yaguang Weng; Tongchuan He; Yan Zhang
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more
  30 in total

1.  Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events.

Authors:  Jose M Ayuso; Rosa Monge; Alicia Martínez-González; María Virumbrales-Muñoz; Guillermo A Llamazares; Javier Berganzo; Aurelio Hernández-Laín; Jorge Santolaria; Manuel Doblaré; Christopher Hubert; Jeremy N Rich; Pilar Sánchez-Gómez; Víctor M Pérez-García; Ignacio Ochoa; Luis J Fernández
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

Review 2.  Toward a Cancer Drug of Fungal Origin.

Authors:  Alexander Kornienko; Antonio Evidente; Maurizio Vurro; Véronique Mathieu; Alessio Cimmino; Marco Evidente; Willem A L van Otterlo; Ramesh Dasari; Florence Lefranc; Robert Kiss
Journal:  Med Res Rev       Date:  2015-04-08       Impact factor: 12.944

3.  Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling.

Authors:  Banu Iskender; Kenan Izgi; Esra Hizar; Johann Jauch; Aslihan Arslanhan; Esra Hilal Yuksek; Halit Canatan
Journal:  Tumour Biol       Date:  2015-12-30

4.  De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer.

Authors:  Naser Jafari; James Drury; Andrew J Morris; Fredrick O Onono; Payton D Stevens; Tianyan Gao; Jinpeng Liu; Chi Wang; Eun Y Lee; Heidi L Weiss; B Mark Evers; Yekaterina Y Zaytseva
Journal:  Mol Cancer Res       Date:  2018-08-28       Impact factor: 5.852

5.  Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model.

Authors:  Antonio Leo; Rita Citraro; Nicola Amodio; Caterina De Sarro; Maria Eugenia Gallo Cantafio; Andrew Constanti; Giovambattista De Sarro; Emilio Russo
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

6.  FTY720 ameliorates renal fibrosis by simultaneously affecting leucocyte recruitment and TGF-β signalling in fibroblasts.

Authors:  T Tian; J Zhang; X Zhu; S Wen; D Shi; H Zhou
Journal:  Clin Exp Immunol       Date:  2017-07-27       Impact factor: 4.330

7.  Significantly inhibitory effects of low molecular weight heparin (Fraxiparine) on the motility of lung cancer cells and its related mechanism.

Authors:  Guo-xing Zhong; Yi Gong; Chuan-jiang Yu; Shi-fei Wu; Qing-ping Ma; Yu Wang; Jiang Ren; Xue-chao Zhang; Wei-han Yang; Wen Zhu
Journal:  Tumour Biol       Date:  2015-01-27

Review 8.  Glioblastoma: Current Status, Emerging Targets, and Recent Advances.

Authors:  Amandeep Thakur; Chetna Faujdar; Ram Sharma; Sachin Sharma; Basant Malik; Kunal Nepali; Jing Ping Liou
Journal:  J Med Chem       Date:  2022-07-05       Impact factor: 8.039

9.  The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells.

Authors:  Fahim Atif; Neil R Patel; Seema Yousuf; Donald G Stein
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

Review 10.  The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod.

Authors:  Sathya Narayanan Patmanathan; Lee Fah Yap; Paul G Murray; Ian C Paterson
Journal:  J Cell Mol Med       Date:  2015-07-14       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.